Octavian Therapeutics
Manufacturing · United Kingdom · 1-10 Employees
View Company Info for Free
Overview
Headquarters
267 Banbury Rd, Oxford, Oxfordshire, OX2...Phone Number
+44 2030342820Website
www.oxcantech.comRevenue
<$5 MillionStock Symbol
OCTPIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Octavian Therapeutics
Octavian is a biopharma company focused on developing innovative, small-molecule drugs that target the endocannabinoid system to treat chronic pain and other under-researched conditions. The company aims to provide breakthrough, non-addictive treatments to reduce reliance on opioids. With a team experienced in pharmaceutical operations and a strong track record of regulatory approvals, Octavian is dedicated to delivering effective therapies for debilitating conditions. Their pipeline includes a variety of compounds designed to address the needs of patients suffering from chronic pain.Explore more
Popular SearchesOxford Cannabinoid TechnologiesOxford Professional ConsultingOxford Cannabinoid Technologies Holdings PLCOxford Cannabinoid Technologies LtdOXFORD - CAMBRIDGE CENTRE FOR ADVANCED MANAGEMENT ...SIC Code 28,283NAICS Code 32,325Ticker LON: OCTPShow moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Octavian Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Octavian Therapeutics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Octavian Therapeutics has new funding data
Check out if Octavian Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Octavian Therapeutics
Check if Octavian Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Octavian Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Octavian Therapeutics launches new products
Earning: See what the market has to say on Octavian Therapeutics recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Octavian Therapeutics as Masked Content
Find 2 more new buyers
Compare Similar Companies to Octavian Therapeutics
Compare insights from companies similar to Octavian Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Octavian Therapeutics
<$5M
1-10
Public
-
2017
N/A
Company Profile Activity
Activity Insights
Octavian Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Octavian Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Octavian Therapeutics.
Octavian Therapeutics Tech Stack
A closer look at the technologies used by Octavian Therapeutics
Most Recent Scoops
New Hire
Executive Move
Promotion
Executive Move
Lateral Move
Executive Move
Promotion
Executive Move
Left Company
Executive Move
Octavian Therapeutics News & Media
Oxford Cannabinoid Technologies Holdings Plc Reports Earnings Results for the Half Year ...
Oxford Cannabinoid Technologies Holdings Plc reported earnings results for the half year ended October 31, 2023. For the half year, the company reported net loss was GBP 2 million compared to GBP 3.71...Oxford Cannabinoid Technologies Files Patent for New Cannabinoid Compound in Europe
-- Oxford Cannabinoid Technologies filed for a new European patent for its Delta-9-tetrahydrocannabinol and Cannabidiol compound. The new compound is based on the prescription cannabinoid medicines...Oxford Cannabinoid Technologies strengthens board with CMO Dr. Tim Corn
Oxford Cannabinoid Technologies Holdings PLC CEO Clarissa Sowemimo Coker and CMO Dr Tim Corn speak to Thomas Warner from Proactive after the pharmaceutical group announced the appoint of Corn to its...Oxford Cannabinoid Technologies Holdings plc Appoints Tim Corn as an Executive Director
Oxford Cannabinoid Technologies Holdings plc announced the following Board appointment. The Company announced the appointment of Dr. Tim Corn, Chief Medical Officer , as an executive director,...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Octavian Therapeutics
Sign Up For FreeTo access detailed company insights
Octavian is a biopharma company focused on developing innovative, small-molecule drugs that target the endocannabinoid system to treat chronic pain and other under-researched conditions. The company aims to provide breakthrough, non-addictive treatments to reduce reliance on opioids. With a team experienced in pharmaceutical operations and a strong... Read More
